Impact of NLP Methods on Clinical Practice and Future Clinical Trials

Bernardo H. Goulart, MD, MS of Seattle Cancer Care Alliance explains the impact of natural language processing (NLP) on future clinical practice and trials. This was recorded at the 2017 ASCO Annual Meeting in Chicago, IL.

Abstract 6528: Validation of natural language processing (NLP) for automated ascertainment of EGFR and ALK tests in SEER cases of non-small cell lung cancer (NSCLC).